---
$id: https://graph.org.ai/products/commodity/51282922
$type: Product
source: UNSPSC
code: "51282922"
title: "Merafloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Merafloxacin

**UNSPSC Code**: 51282922
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C19H23F2N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G6U51T1K77, chemically known as 3-quinolinecarboxylic acid, 1-ethyl-7-(3-((ethylamino)methyl)-1-pyrrolidinyl)-6,8-difluoro-1,4-dihydro-4-oxo- but generally known as merafloxacin, which bears US NIH Compound Identifier 121833. European Medicines Agency schedules Merafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08767MIG. The term MERAFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). MERAFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule merafloxacin under HS 29334910 and SITC 51575. As of Q4 2014, MERAFLOXACIN remains the US FDA Preferred Term for this commodity. Merafloxacin bears US NLM identifiers UMLS ID C0089342 and NCI Concept Code C83932. SMILES: FC1C(N2CC(CC2)CNCC)C(F)CC2C1N(CC)CC(C2=O)C(=O)O.

